Elevated serum S-100B levels in children with temporal lobe epilepsy
dc.contributor.author | Calik M. | |
dc.contributor.author | Abuhandan M. | |
dc.contributor.author | Sonmezler A. | |
dc.contributor.author | Kandemir H. | |
dc.contributor.author | Oz I. | |
dc.contributor.author | Taskin A. | |
dc.contributor.author | Iscan A. | |
dc.date.accessioned | 2019-08-01T13:38:39Z | |
dc.date.available | 2019-08-01T13:38:39Z | |
dc.date.issued | 2013 | |
dc.department | Niğde ÖHÜ | |
dc.description.abstract | Purpose: An elevated level of S-100B in serum is generally considered to be a biochemical marker of nervous tissue damage. According to our knowledge, no studies have evaluated the serum S-100B protein concentration in children with temporal lobe epilepsy. The objective of this study was to measure the serum levels of S-100B protein in pediatric cases with temporal epilepsy. Methods: This case-controlled cross-sectional study was performed at the Department of Pediatric Neurology, Harran University School of Medicine, Sanliurfa, in Turkey. Serum S-100B protein levels were studied in 19 (12 females, 7 males) children with temporal lobe epilepsy and in 25 (15 females, 10 males) healthy control subjects. Serum samples were collected within 30 min after a complex partial seizure, and serum S-100B protein levels were measured with an electrochemiluminescence immunoassay for the quantification of protein (ECLIA kit, Roche® Diagnostics, Germany). Results: The mean serum concentration of S-100B protein was 0.12 ± 0.02 µg/L in the temporal lobe epilepsy group and 0.07 ± 0.01 µg/L in the control group. The patients showed significantly elevated S-100B protein levels compared with healthy controls (P < 0.001). Conclusion: Our data suggest that increased S-100B protein levels in the serum might reflect neuronal damage in the brains of children with temporal lobe epilepsy. These results do confirm the previous findings of elevated S-100B protein levels in adult patients with temporal lobe epilepsy. © 2012 British Epilepsy Association. | |
dc.identifier.doi | 10.1016/j.seizure.2012.10.012 | |
dc.identifier.endpage | 102 | |
dc.identifier.issn | 1059-1311 | |
dc.identifier.issue | 2 | |
dc.identifier.pmid | 23146618 | |
dc.identifier.startpage | 99 | |
dc.identifier.uri | https://dx.doi.org/10.1016/j.seizure.2012.10.012 | |
dc.identifier.uri | https://hdl.handle.net/11480/840 | |
dc.identifier.volume | 22 | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | [0-Belirlenecek] | |
dc.language.iso | en | |
dc.relation.ispartof | Seizure | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Biochemical marker | |
dc.subject | Children | |
dc.subject | S-100B level | |
dc.subject | Temporal lobe epilepsy | |
dc.title | Elevated serum S-100B levels in children with temporal lobe epilepsy | |
dc.type | Article |